193 related articles for article (PubMed ID: 6189039)
21. Chemotherapy of bronchogenic carcinomas by a combination of cyclophosphamide, methotrexate, vincristin and bleomycin.
Schaerer R; Sotto JJ; Wiget U; Perdrix A; Bensa JC; Ribaud P
Eur J Cancer (1965); 1977; 13(4-5):425-8. PubMed ID: 68881
[No Abstract] [Full Text] [Related]
22. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Miller CF; Weltz MD; Heim WJ; Blom J
Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
[No Abstract] [Full Text] [Related]
23. Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan.
Bonadonna G; Tancini G; Bajetta E
Cancer Chemother Rep 3; 1973 Mar; 4(2):231-7. PubMed ID: 4125741
[No Abstract] [Full Text] [Related]
24. Combination chemotherapy with adriamycin, cyclophosphamide, methotrexate and vincristine in lung cancer patients with extensive disease.
Kolarić K; Roth A; Vukas D
Tumori; 1979 Oct; 65(5):635-42. PubMed ID: 229601
[No Abstract] [Full Text] [Related]
25. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
Ruckdeschel JC; Mehta CR; Salazar OM; Creech RH; Sponzo RW
Cancer Treat Rep; 1981; 65(11-12):959-63. PubMed ID: 6794909
[TBL] [Abstract][Full Text] [Related]
26. Treatment of bronchogenic carcinoma with simultaneous or sequential combination chemotherapy, including methotrexate, cyclophosphamide, procarbazine and vincristine.
Alberto P; Brunner KW; Martz G; Obrecht J; Sonntag RW
Cancer; 1976 Dec; 38(6):2208-16. PubMed ID: 187313
[TBL] [Abstract][Full Text] [Related]
27. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
28. [Cytostatic therapy of tumors of the lung].
De Marco F; Saviano G; Tenore G
Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
[No Abstract] [Full Text] [Related]
29. Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
Valdivieso M; Cabanillas F; Keating M; Barkley HT; Murphy WK; Burgess MA; Frazier H; Chen T; Bodey GP
Am J Med; 1984 Mar; 76(3):405-12. PubMed ID: 6322584
[TBL] [Abstract][Full Text] [Related]
30. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
[TBL] [Abstract][Full Text] [Related]
31. Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).
Jones DH; Bleehen NM; Grant RM; Plowman PN; Roberts JT; Sikora K; Watson JV; Wiltshire CR
Anticancer Res; 1983; 3(4):235-8. PubMed ID: 6192751
[TBL] [Abstract][Full Text] [Related]
32. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
33. Cancer chemotherapeutic response and intravenous hyperalimentaion.
Lanzotti VJ; Copeland EM; George SL; Dudrick SJ; Samuels ML
Cancer Chemother Rep; 1975; 59(2 Pt 1):437-9. PubMed ID: 50127
[No Abstract] [Full Text] [Related]
34. Management of small cell cancer: intensive chemotherapy.
Smyth JF; Gregor A
Recent Results Cancer Res; 1984; 92():58-64. PubMed ID: 6330811
[No Abstract] [Full Text] [Related]
35. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
37. [VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Ryssel HJ; Hasler E; Sonntag RW; Cavalli F; Martin J; Tschopp L; Brunner KW
Schweiz Med Wochenschr; 1977 Jul; 107(26):912-5. PubMed ID: 877537
[TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
[TBL] [Abstract][Full Text] [Related]
39. A comparison between a single agent short course chemotherapy regimen and a quadruple prolonged course regimen for small-cell bronchogenic carcinoma of limited extent.
Carroll KB; Moussalli H; Brown D; Thatcher N
Br J Dis Chest; 1983 Apr; 77(2):171-8. PubMed ID: 6307334
[TBL] [Abstract][Full Text] [Related]
40. [Polychemotherapy in inoperable bronchial carcinoma].
Schmidt CG
Strahlentherapie; 1984 Feb; 160(2):71-6. PubMed ID: 6328699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
